SyntekaBio, Inc. (KOSDAQ:226330)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,170.00
-30.00 (-0.48%)
Last updated: Aug 14, 2025

SyntekaBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
94,14580,107216,882115,982241,650307,326
Market Cap Growth
-39.68%-63.06%87.00%-52.00%-21.37%-
Enterprise Value
100,67571,044189,59186,513201,583-
Last Close Price
6170.005250.0014240.008580.0017900.0023000.00
PS Ratio
95.73662.661757.47475.35763.13504.08
PB Ratio
5.313.216.953.698.757.40
P/TBV Ratio
5.433.277.053.768.897.48
EV/Sales Ratio
102.37587.691536.32354.57636.59-
Debt / Equity Ratio
1.020.290.070.350.320.03
Asset Turnover
0.020.000.000.000.01-
Quick Ratio
0.510.741.021.5928.0039.87
Current Ratio
0.540.771.131.6930.8240.04
Return on Equity (ROE)
-55.82%-25.68%-36.36%-15.25%-42.80%-
Return on Assets (ROA)
-19.37%-18.46%-14.13%-11.93%-9.87%-
Return on Capital (ROIC)
-25.47%-27.20%-20.22%-18.65%-14.06%-
Earnings Yield
-14.37%-9.00%-5.25%-3.89%-6.13%-2.11%
FCF Yield
-14.00%-20.24%-8.04%-14.57%-5.59%-1.78%
Buyback Yield / Dilution
-3.47%-24.72%-5.94%-0.37%-1.65%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.